MEDIPOST Co., Ltd.

ACTIVE

京畿道城南市, 京畿道, South Koreawww.medi-post.co.krPublic290 employeesEstablished: 2000-01-01

Clinical Trials

2 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2000

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

44.4%

Phase 2

27.8%

Not Applicable

11.1%

Phase 3

11.1%

Trial Status Distribution

Active, not recruiting

11.1%

Completed

83.3%

Recruiting

5.6%

Clinical Trials

Trials sponsored by this organization (18)

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

Phase 2

Active, not recruiting

interventional

Mar 202384 participants

Clinical Trial to Evaluate Efficacy and Safety of SMUP-IA-01 in Patients With Knee Osteoarthritis

Phase 2

Completed

interventional

Feb 202294 participants

Follow-up Safety and Efficacy Evaluation on Subjects Who Completed Phase I Clinical Trial

Phase 1

Recruiting

interventional

Apr 202012 participants

Evaluate Safety and Explore Efficacy of SMUP-IA-01 in Patients With Knee Osteoarthritis

Phase 1

Completed

interventional

Oct 201912 participants

Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial

Phase 2

Active, not recruiting

interventional

Jul 201960 participants

Hair Growth Efficacy and Safety of NGF-574H in Adult With Androgenic Alopecia

Not Applicable

Completed

interventional

Oct 201884 participants

PNEUMOSTEM for the Prevention and Treatment of Severe BPD in Premature Infants

Phase 2

Completed

interventional

Aug 201860 participants

Follow-up Study of Safety and Efficacy in Subjects Who Completed NEUROSTEM® Phase-I/IIa Clinical Trial.

Phase 1

Completed

interventional

May 201736 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations